Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIKAL. ZYDUS LIFESCIENCES HIKAL./
ZYDUS LIFESCIENCES
 
P/E (TTM) x 45.6 34.2 133.1% View Chart
P/BV x 2.9 5.8 49.9% View Chart
Dividend Yield % 0.5 0.6 75.9%  

Financials

 HIKAL.   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    HIKAL.
Mar-23
ZYDUS LIFESCIENCES
Mar-23
HIKAL./
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs456495 92.2%   
Low Rs216319 67.5%   
Sales per share (Unadj.) Rs164.1170.3 96.3%  
Earnings per share (Unadj.) Rs6.419.8 32.1%  
Cash flow per share (Unadj.) Rs15.226.9 56.5%  
Dividends per share (Unadj.) Rs1.206.00 20.0%  
Avg Dividend yield %0.41.5 24.2%  
Book value per share (Unadj.) Rs91.9173.0 53.1%  
Shares outstanding (eoy) m123.301,012.20 12.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.4 85.6%   
Avg P/E ratio x52.820.6 256.7%  
P/CF ratio (eoy) x22.115.1 146.1%  
Price / Book Value ratio x3.72.4 155.3%  
Dividend payout %18.930.3 62.2%   
Avg Mkt Cap Rs m41,420412,144 10.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,22424,564 9.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,230172,374 11.7%  
Other income Rs m544,746 1.1%   
Total revenues Rs m20,284177,120 11.5%   
Gross profit Rs m2,57129,677 8.7%  
Depreciation Rs m1,0907,227 15.1%   
Interest Rs m4811,299 37.0%   
Profit before tax Rs m1,05425,897 4.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2705,878 4.6%   
Profit after tax Rs m78420,019 3.9%  
Gross profit margin %12.717.2 73.8%  
Effective tax rate %25.622.7 112.8%   
Net profit margin %3.911.6 33.4%  
BALANCE SHEET DATA
Current assets Rs m9,683100,082 9.7%   
Current liabilities Rs m6,90855,267 12.5%   
Net working cap to sales %13.726.0 52.8%  
Current ratio x1.41.8 77.4%  
Inventory Days Days2650 50.9%  
Debtors Days Days8094 85.2%  
Net fixed assets Rs m15,024144,776 10.4%   
Share capital Rs m2471,012 24.4%   
"Free" reserves Rs m11,088174,146 6.4%   
Net worth Rs m11,335175,158 6.5%   
Long term debt Rs m4,8990-   
Total assets Rs m24,707244,940 10.1%  
Interest coverage x3.220.9 15.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.80.7 116.4%   
Return on assets %5.18.7 58.8%  
Return on equity %6.911.4 60.5%  
Return on capital %9.515.5 60.9%  
Exports to sales %67.639.2 172.5%   
Imports to sales %25.611.9 215.0%   
Exports (fob) Rs m13,68467,577 20.3%   
Imports (cif) Rs m5,18420,544 25.2%   
Fx inflow Rs m13,68467,577 20.3%   
Fx outflow Rs m5,18420,544 25.2%   
Net fx Rs m8,50047,033 18.1%   
CASH FLOW
From Operations Rs m3,15326,888 11.7%  
From Investments Rs m-2,92311,712 -25.0%  
From Financial Activity Rs m-77-44,004 0.2%  
Net Cashflow Rs m153-5,338 -2.9%  

Share Holding

Indian Promoters % 68.9 75.0 91.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.3 18.0 51.5%  
FIIs % 6.1 5.0 123.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.2 25.0 124.5%  
Shareholders   74,657 306,495 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIKAL. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on HIKAL CHEMIC vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

HIKAL CHEMIC vs Cadila Healthcare Share Price Performance

Period HIKAL CHEMIC Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.21% 0.57% 1.18%
1-Month -5.48% 7.77% -0.75%
1-Year -1.62% 107.52% 61.82%
3-Year CAGR 22.19% 32.30% 18.16%
5-Year CAGR 9.04% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the HIKAL CHEMIC share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of HIKAL CHEMIC hold a 68.9% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of HIKAL CHEMIC and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, HIKAL CHEMIC paid a dividend of Rs 1.2 per share. This amounted to a Dividend Payout ratio of 18.9%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of HIKAL CHEMIC, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.